Kratos Defense (KTOS) Q3 2026 Earnings Call Transcript

Kratos reported Q3 2026 revenue of $471.8 million, up 35.7% year over year, and adjusted EBITDA of $50.9 million, above its $40–$45 million guidance range; bookings were $1.037 billion, with a 2.2:1 book-to-bill ratio and record backlog of $2.65 billion. Management forecast 2027 revenue of $2.1–$2.2 billion and adjusted EBITDA of $230–$240 million, while targeting approximately $700 million of hypersonics revenue in 2027. The outlook is supported by production ramps and new contracts, but management cited supply-chain and staffing constraints, a continuing-resolution risk, and $29.4 million of Q3 free cash flow use; it expects sustained positive cash flow by 2029.

Analysis

The key underwriting question is conversion, not demand: backlog and bookings can support a growth multiple only if government awards become deliverable production and then cash. KTOS is front-loading inventory, facilities, and supplier commitments while collections are stretching; this creates a meaningful gap between reported EBITDA and equity cash generation through the ramp. The 2027 engine plan illustrates the timing mismatch: supply-chain purchases precede much of the planned shipment revenue, while further orders could renew the working-capital draw. Thus, the stated 2029 cash-flow inflection is a multi-year execution thesis, not a near-term payoff.

Near term, the next useful evidence is Q4 segment guidance and cash conversion, rather than another pipeline or opportunity figure. In 1–3 months, watch appropriation/continuing-resolution developments and whether Valkyrie LRIP contributes identifiable revenue. Through 2027, range access, qualified labor, single-source components, and production yields can defer shipments even with funded programs. Fixed-price exposure makes cost or schedule slippage more consequential; cost-plus work moderates some downside but structurally limits margin upside. Shekel strength is a specific headwind to the Israeli microwave operation, not a broad KTOS thesis.

The strategic upside is credible if affordable engines, drones, and hardware scale: primes including LMT, RTX, and LDOS may gain from expanded program capacity while facing potential value capture moving toward specialized suppliers. GE Aerospace’s co-development/second-source role is strategically relevant, but does not establish near-term material earnings contribution. Contrarian point: cautious consolidated guidance may leave room for upside, but management’s confidence and large pipeline should not be treated as committed revenue. Without valuation and current price data, avoid chasing a post-call move.

Key Decisions for Investors

• KTOS: Do not chase an immediate earnings-driven gap. Consider a staged long on weakness only if Q4 segment disclosure supports Valkyrie/engine ramp and DSO stabilizes; the upside case is production conversion, while the principal downside is cash absorption or delayed deliveries. No price target without valuation and market-price inputs.
• Track Q4 results and the next guidance update as the 1–3 month catalyst. Require evidence of backlog conversion alongside operating cash flow, receivables, and inventory; rising DSO with weak cash conversion would falsify the near-term execution case even if EBITDA beats.
• Set a 2027 alert on the continuing-resolution deadline, range scheduling, supplier delivery, and clearance-qualified hiring. A funding delay beyond management’s stated assumption or material program slippage should trigger a reassessment of the growth thesis, not an automatic buy-the-dip.
• Treat GE Aerospace, LMT, RTX, and LDOS as read-through names, not immediate derivative trades: verify contract economics and revenue contribution before positioning. The article does not establish enough independent detail to size a supplier or competitor trade.